The effect of a commercially available bacteriophage and bacteriocin on Listeria monocytogenes in coleslaw
dc.contributor.author | Lewis, Rhea | |
dc.contributor.author | Bolocan, Andrei Sorin | |
dc.contributor.author | Draper, Lorraine A. | |
dc.contributor.author | Ross, R. Paul | |
dc.contributor.author | Hill, Colin | |
dc.contributor.funder | Science Foundation Ireland | en |
dc.date.accessioned | 2019-12-04T09:36:05Z | |
dc.date.available | 2019-12-04T09:36:05Z | |
dc.date.issued | 2019-10-23 | |
dc.description.abstract | Changing consumer attitudes show an increased interest in non-chemical antimicrobials in food preservation and safety. This greater interest of consumers in more ‘natural’ or ‘clean-label’ food interventions is complicated by concurrent demands for minimally processed, ready-to-eat (RTE) foods with long shelf lives. Two viable interventions are bacteriophage (phage) and bacteriocins, a number of which have already been approved for use in food safety. Listeriosis is a serious foodborne infection which affects at-risk members of the population. Listeriosis incidence has increased between 2008 and 2015 and has a case fatality rate of up to 20% with antibiotic intervention. Here, we tested an intervention to attempt to control a pathogenic Listeria monocytogenes strain in a food model using two of these alternative antimicrobials. Phage P100 on its own had a significant effect on L. monocytogenes ScottA numbers in coleslaw over a 10-day period at 4 °C (p ≤ 0.001). A combination of P100 and Nisaplin® (a commercial formulation of the lantibiotic bacteriocin, nisin) had a significant effect on the pathogen (p ≤ 0.001). P100 and Nisaplin® in combination were more effective than Nisaplin® alone, but not P100 alone. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | 977 | en |
dc.identifier.citation | Lewis, R., Bolocan, A. S., Draper, L. A., Ross, R. P. and Hill, C. (2019) 'The Effect of a Commercially Available Bacteriophage and Bacteriocin on Listeria monocytogenes in Coleslaw', Viruses, 11(11), 977. (12pp.) doi: 10.3390/v11110977 | en |
dc.identifier.doi | 10.3390/v11110977 | en |
dc.identifier.eissn | 1999-4915 | |
dc.identifier.endpage | 12 | en |
dc.identifier.issued | 11 | en |
dc.identifier.journaltitle | Viruses | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/9309 | |
dc.identifier.volume | 11 | en |
dc.language.iso | en | en |
dc.publisher | MDPI | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2273/IE/Alimentary Pharmabiotic Centre (APC) - Interfacing Food & Medicine/ | en |
dc.rights | ©2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Phage | en |
dc.subject | Bacteriocin | en |
dc.subject | Listeria monoytogenes | en |
dc.subject | Food safety | en |
dc.title | The effect of a commercially available bacteriophage and bacteriocin on Listeria monocytogenes in coleslaw | en |
dc.type | Article (peer-reviewed) | en |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: